Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: A distributed ambulatory research in therapeutics network (DARTNet) study

Journal of the American Board of Family Medicine

Volumn 26, Issue 5, 2013, Pages 529-538

  Bronsert, Michael R ^a   Henderson, William G ^a,b   Valuck, Robert ^c   Hosokawa, Patrick ^a   Hammermeister, Karl ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Antihypertensives; Comparative effectiveness research; Drug therapy; Hypertension; Practice based research; Primary health care

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; COMPARATIVE EFFECTIVENESS; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVES; COMPARATIVE EFFECTIVENESS RESEARCH; DRUG THERAPY; HYPERTENSION; PRACTICE-BASED RESEARCH; PRIMARY HEALTH CARE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; RISK ADJUSTMENT; SODIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 84883706651     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2013.05.130048     Document Type: Article

References (23)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:188 -97.
2. Lewington S, Clarke R, Qizibash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies: prospective studies collaboration. Lancet 2002;360:1903-13.
3. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
4. Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration: effects of different bloodpressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003;362:1527-35.
5. Chobanian AV, Bakris GL, Black HR, et al.; the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206 -52.
6. Cushman WC, Ford CE, Cutler JA, et al.; ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4: 393-404.
7. Bakris GL, Weir MR; Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators. Achieving goal blood pressure in patients with type 2 diabetes: Conventional versus fixed-dose combination approaches. J Clin Hypertens (Greenwich) 2003;5:202-9.
8. Brown MJ, McInnes GT, Papst CC, Zhang J, Mac-Donald TM. Aliskiren and the calcium channel blocker Amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 2011;377:312-20.
9. Neutel JM, Mancia G, Black HR, et al.; TEAMSTA Severe HTN Study Investigators. Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA Severe HTN Study. J Clin Hypertens (Greenwich) 2012;14:206 -15.
10. Baser O, Andrews LM, Wang L, Xie L. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine singe-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. J Med Econ 2011;14:576-83.
11. Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single-pill vs. free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens 2011;13:898 -909.
12. Libby AM, Pace W, Bryan C, et al. Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes. Med Care 2010;48: S39-44.
13. Pace WD, Cifuentes M, Valuck RJ, Staton EW, Brandt EC, West DR. An electronic practice-based network for observational comparative effectiveness research. Ann Intern Med 2009;151:338-40.
14. Pace WD, West DR, Valuck RJ, Cifuentes M, Staton EW. Distributed Ambulatory Research in Therapeutics Network (DARTNet): summary report (prepared by University of Colorado DEcIDE Center under contract no. HHSA29020050037I TO2). Report No. 14. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
15. Levely AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604 -12.
16. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427.
17. Neaton JD, Grimm RH, Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. JAMA 1993;270: 713-24.
18. Cushman WC, Ford CE, Einhorn PT, et al.; ALLHAT Collaborative Research Group. Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2008;10:751- 60.
19. Materson BJ, Reda DJ, Cushman WC, et al. Singledrug therapy for hypertension in men. N engl J Med 1993;328:914 -21.
20. Byrd JB, Zeng C, Tavel HM, et al. Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J 2011;162:340-6.
21. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenber KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension 2012;59:1124 -31.
22. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:42-50.
23. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:243-62.